| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |